Supplement guide · Memory and focus

Ginkgo Biloba: Memory, Focus and Dementia

📄 25 PubMed citations

Two large prevention trials, with 3,069 and 2,854 older adults, found that ginkgo did not prevent dementia or Alzheimer disease. Trials in people who already have dementia tell a different and less certain story.

🔬 Ginkgo is sold as a memory supplement for everyone, but the trial record splits by who took it. We sorted the evidence into three groups: healthy adults, older adults trying to prevent dementia, and people already diagnosed with dementia. The results differ between them, so a single verdict on ginkgo for memory would mislead. We kept the standardized extract EGb 761 separate from generic ginkgo products, because most of the positive dementia data come from that one extract and product tests show wide variation in what store-bought ginkgo contains. Bleeding gets its own section because the clotting trials and the case reports point in different directions.
3,069
Adults aged 75 or older in the GEM trial, where ginkgo did not lower dementia rates
82
Studies in the 2026 Cochrane review of ginkgo for cognitive impairment and dementia
8 of 18
Commercial ginkgo supplements found adulterated in one lab fingerprint study
Older adults seated at tables in a bright community hall, chatting over tea, one man in blue jacket in foreground
Photo: CRCASA · CC0 1.0 · source

Build your own printable peptide tracker

A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Stacking compounds? Check interactions first →

Build your tracker →

How Is Ginkgo Thought to Work?

🍃
What a standardized extract contains

The standardized leaf extract EGb 761 contains two main groups of active compounds, flavonoid glycosides (24%) and terpene lactones (6%), with less than 5 ppm of ginkgolic acid, the allergenic component. Proposed actions include antioxidant, antiplatelet and microcirculatory effects (Ginkgo chemistry and safety review, PMID 18211362).

🧠
Blood flow in the brain

In 9 healthy men with a mean age of 61, 4 weeks of 60 mg ginkgo extract twice daily was followed by a small but significant rise in global cerebral blood flow on MRI perfusion scans, about 13% in gray matter and 15% in white matter. The pilot had no placebo group (ginkgo MR perfusion pilot, PMID 21061003).

🩸
Blood thickness, not clotting time

Across 18 randomized trials with 1,985 adults, standardized ginkgo extract lowered blood viscosity but had no significant effect on ADP-induced platelet aggregation, fibrinogen, aPTT or prothrombin time (ginkgo bleeding meta-analysis, PMID 21923430).

😴
Sleep in depression, one small pilot

In an open, non-randomized pilot of 16 depressed inpatients on trimipramine, the 8 who added 240 mg a day of ginkgo extract for 4 weeks had higher sleep efficiency and fewer awakenings on sleep recordings. Stopping ginkgo reversed most of these effects (adjunct ginkgo polysomnography pilot, PMID 11302564).

What the Data Shows

Dementia, EGb 761 for 22 to 26 weeks
Cognition improved more than on placebo, standardized mean difference -0.52 (95% CI -0.98 to -0.05), 2,625 patients in 7 trials (EGb 761 dementia meta-analysis; PMID 25506211)
SMD -0.52
Dementia, Cochrane 2026
Possible small to moderate benefits for cognition, daily activities and global status at 6 months, from low-certainty evidence (Cochrane ginkgo for cognitive impairment and dementia; PMID 41641880)
small, low certainty
Mild cognitive impairment, Cochrane 2026
Little to no effect on ADAS-cog cognition at 6 months, mean difference -0.07 points, 508 people in 2 studies (Cochrane review; PMID 41641880)
-0.07 points
Dementia prevention, GuidAge, 5 years
61 Alzheimer cases on ginkgo vs 73 on placebo, hazard ratio 0.84 (95% CI 0.60 to 1.18; p = 0.306), not significant (GuidAge trial; PMID 22959217)
HR 0.84, ns
Dementia prevention, GEM, 6.1 years
277 dementia cases on ginkgo vs 246 on placebo, hazard ratio 1.12 (95% CI 0.94 to 1.33; P = .21) (Ginkgo Evaluation of Memory trial; PMID 19017911)
HR 1.12, ns
Healthy adults, memory
Effect size d = -0.04 for memory across 13 trials with 1,132 participants, close to zero (healthy-individual cognition meta-analysis; PMID 23001963)
d = -0.04

Daily Dosing Schedule

TimeCompounds
Diagnosed dementia, 22 to 26 weeksEGb 761 at 240 mg a day. The meta-analysis tied most of the benefit to this dose (EGb 761 meta-analysis of 9 trials, PMID 25114079).
Dementia prevention, 5 to 6 years120 mg of extract twice a day. Neither GEM nor GuidAge found fewer dementia or Alzheimer cases than on placebo (GEM, PMID 19017911; GuidAge, PMID 22959217).
Healthy adults over 60, 6 weeks40 mg three times a day, following the manufacturer instructions. No outcome differed from placebo (ginkgo memory enhancement trial, PMID 12186600).
Anxiety, 4 weeksEGb 761 at 240 mg or 480 mg a day in generalized anxiety disorder or adjustment disorder with anxious mood (EGb 761 anxiety trial, PMID 16808927).
Single dose, healthy young adults120 mg, 240 mg or 360 mg of a standardized extract, tested over 6 hours (acute ginkgo dose study, PMID 11026748).

Key Takeaways

What We Know
  • Ginkgo did not prevent dementia in the GEM trial. Among 3,069 adults aged 75 or older followed for a median of 6.1 years, 120 mg twice a day gave a hazard ratio of 1.12 for all-cause dementia versus placebo (PMID 19017911), and it did not slow cognitive decline in any domain tested (PMID 20040554).
  • GuidAge, a 5-year French trial of 2,854 adults aged 70 or older with memory complaints, found 61 Alzheimer cases on EGb 761 and 73 on placebo, a difference that was not significant (PMID 22959217).
  • In healthy people, a meta-analysis found effect sizes close to zero for memory, executive function and attention (PMID 23001963), and a 6-week trial in 230 adults over 60 found no difference from placebo on any outcome (PMID 12186600).
  • In diagnosed dementia, a meta-analysis of 7 trials found EGb 761 improved cognition, daily activities and global ratings more than placebo over 22 to 26 weeks (PMID 25506211). The 2026 Cochrane review rated the dementia evidence low certainty and found little to no effect in mild cognitive impairment (PMID 41641880).
  • In dementia with behavioral and psychological symptoms, 240 mg a day of EGb 761 for 22 to 24 weeks improved those symptoms, except psychotic-like features, across 4 trials with 1,628 patients (PMID 28931444).
  • In 107 patients with generalized anxiety disorder or adjustment disorder with anxious mood, Hamilton Anxiety scores fell 14.3 points on 480 mg, 12.1 on 240 mg and 7.8 on placebo over 4 weeks (PMID 16808927).
  • In clotting studies, ginkgo did not change warfarin levels or INR in 12 healthy men (PMID 15801937), and adding 240 mg EGb 761 to 500 mg aspirin did not lengthen bleeding time beyond aspirin alone in 50 healthy men (PMID 16752942).
What We Don't Know
  • Why the dementia results vary so much. The Cochrane dementia estimates showed high heterogeneity (I² of 88% to 96%) (PMID 41641880), and one meta-analysis found no extra benefit in its Alzheimer disease subgroup over the whole group (PMID 25114079).
  • Whether ginkgo causes serious bleeding. A review of 15 case reports, 8 of them intracranial bleeds, judged a causal link possible, though 13 reports had other bleeding risk factors (PMID 16050865). The trial with aspirin lasted 4 weeks and was small (PMID 17982321).
  • What a given bottle contains. In one lab study, 8 of 18 commercial ginkgo supplements were adulterated, mostly with rutin or quercetin (PMID 23451372). Products on the US market ranged from under 500 ppm to about 90,000 ppm of ginkgolic acids (PMID 12005361).
  • What the rodent cancer finding means for people. In 2-year gavage studies by the National Toxicology Program, hepatocellular carcinoma rose in every dosed group of male mice, at 200 to 2,000 mg per kg of body weight (PMID 23652021).
  • Whether ginkgo helps tinnitus. A Cochrane review of 12 studies with 1,915 participants found the evidence very uncertain, with little to no effect on symptom severity in the pooled data (PMID 36383762).
  • Whether ginkgo helps sleep. The only sleep data here come from an open pilot of 16 depressed inpatients, without randomization (PMID 11302564).
  • What single doses do to focus. Single doses of 240 mg and 360 mg sped attention in 20 young adults (PMID 11026748), while a pooled analysis of 78 young adults found 120 mg improved quality of memory but slowed speed of attention (PMID 17902186).

Frequently Asked Questions

Does ginkgo biloba improve memory?

Not with regular use in healthy adults, going by the trials. A meta-analysis of randomized trials in healthy people found effect sizes close to zero for memory, executive function and attention (ginkgo in healthy individuals meta-analysis, PMID 23001963). In a 6-week trial of 230 adults over 60, the 115 who took 40 mg three times a day did no better than the 115 on placebo on memory tests or self-reported memory (ginkgo memory enhancement trial, PMID 12186600). Single doses are less clear: in 78 healthy young adults, one 120 mg dose improved quality of memory but slowed speed of attention (single-dose 120 mg ginkgo reanalysis, PMID 17902186).

Can ginkgo prevent dementia or Alzheimer disease?

The two large prevention trials say no. In GEM, 3,069 adults aged 75 or older took 120 mg twice a day or placebo for a median of 6.1 years, and dementia rates did not fall (hazard ratio 1.12; Ginkgo Evaluation of Memory trial, PMID 19017911). In GuidAge, 2,854 adults aged 70 or older with memory complaints took EGb 761 for 5 years without a significant drop in Alzheimer cases (GuidAge trial, PMID 22959217).

Does ginkgo help people who already have dementia?

Possibly, by a small amount. A meta-analysis of 7 trials found that EGb 761 at 120 mg or 240 mg a day improved cognition, daily activities and global ratings more than placebo over 22 to 26 weeks (EGb 761 dementia meta-analysis, PMID 25506211). The 2026 Cochrane review described small to moderate benefits at 6 months but rated the evidence low certainty (Cochrane ginkgo for cognitive impairment and dementia, PMID 41641880).

Is ginkgo safe with blood thinners?

The trials and the case reports disagree, so ask a clinician first. A meta-analysis of 18 trials found no significant effect on platelet aggregation or clotting times (ginkgo bleeding meta-analysis, PMID 21923430), and ginkgo did not change warfarin levels or INR in 12 healthy men (ginkgo and warfarin study, PMID 15801937). A review of 15 case reports, including 8 intracranial bleeds, still judged a causal link to bleeding possible (ginkgo bleeding case review, PMID 16050865).

Are ginkgo nuts safe to eat?

Not in large amounts. A 48-year-old man had repeated generalized seizures after overeating ginkgo nuts, with raised blood 4-O-methylpyridoxine and low pyridoxal phosphate, and recovered after pyridoxal phosphate treatment (ginkgo nut intoxication case, PMID 32047675). The trials on this page used leaf extracts, not nuts.

Peer-Reviewed References

Source 1
Ginkgo biloba for prevention of dementia: a randomized controlled trial
JAMA · 2008
PMID: 19017911
Source 2
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial
JAMA · 2009
PMID: 20040554
Source 3
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
Lancet Neurol · 2012
PMID: 22959217
Source 4
Ginkgo biloba for cognitive impairment and dementia
Cochrane Database Syst Rev · 2026
PMID: 41641880
Source 5
Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis
Hum Psychopharmacol · 2012
PMID: 23001963
Source 6
Ginkgo for memory enhancement: a randomized controlled trial
JAMA · 2002
PMID: 12186600
Source 7
Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
Clin Interv Aging · 2014
PMID: 25506211
Source 8
Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis
J Alzheimers Dis · 2015
PMID: 25114079
Source 9
Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials
Int Psychogeriatr · 2018
PMID: 28931444
Source 10
Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial
J Psychiatr Res · 2007
PMID: 16808927
Source 11
Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis
Pharmacotherapy · 2011
PMID: 21923430
Source 12
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects
Br J Clin Pharmacol · 2005
PMID: 15801937
Source 13
Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?
Drugs R D · 2006
PMID: 16752942
Source 14
Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial
Blood Coagul Fibrinolysis · 2007
PMID: 17982321
Source 15
Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature
J Gen Intern Med · 2005
PMID: 16050865
Source 16
Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies)
Natl Toxicol Program Tech Rep Ser · 2013
PMID: 23652021
Source 17
Ginkgo biloba for tinnitus
Cochrane Database Syst Rev · 2022
PMID: 36383762
Source 18
Detection of adulterated Ginkgo biloba supplements using chromatographic and spectral fingerprints
J AOAC Int · 2012
PMID: 23451372
Source 19
Pharmaceutical quality of different Ginkgo biloba brands
J Pharm Pharmacol · 2002
PMID: 12005361
Source 20
Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses
J Food Sci · 2008
PMID: 18211362
Source 21
Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study
Neuroradiology · 2011
PMID: 21061003
Source 22
Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine
Pharmacopsychiatry · 2001
PMID: 11302564
Source 23
Epileptic Seizure from Ginkgo Nut Intoxication in an Adult
Case Rep Emerg Med · 2020
PMID: 32047675
Source 24
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers
Psychopharmacology (Berl) · 2000
PMID: 11026748
Source 25
Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers
Hum Psychopharmacol · 2007
PMID: 17902186
Ebook
The Complete Peptide Protocol Guide

67-page guide: protocols, dosing, sourcing. Everything in one place.

Get the guide: $19 (normally $29) → The Peptide Buyer’s Playbook ($19) All ebooks & guides →
Disclaimer

Educational purposes only. Not medical advice.

Ginkgo is sold in the US as a dietary supplement, not an FDA-approved drug. Talk to a clinician before using it if you take blood thinners, aspirin or other prescription medicines or have a bleeding disorder, or are pregnant.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.